MEI Pharma, Inc. is a pioneering biotech company leading the charge in cancer treatment with innovative therapies that target cancer cell metabolism.

MEI Pharma Inc. has made a groundbreaking $100 million investment in Litecoin, becoming the first publicly traded company to hold the cryptocurrency as a reserve asset.

MEI Pharma Inc, a biotech company, has made a groundbreaking move by investing $100 million in Litecoin, marking a significant pivot in its financial operations and positioning itself as a leader in innovation at the intersection of biotech and cryp…

MEI Pharma Inc is a biotechnology company pioneering a novel approach to cancer treatment by targeting cancer metabolism, with promising research and potential for significant advancements in the field.

MEI Pharma, Inc. is a pioneering biotech company working to revolutionize cancer treatment through innovative therapeutics that target cancer metabolism.

MEI Pharma’s stock has plummeted below its 200-day moving average, raising concerns about the company’s financial stability and ability to translate its promising cancer research into market success.